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In May 2011, an important article on the surgical correction
of cystocele was published in the New England Journal of
Medicine: “Anterior colporrhaphy versus transvaginal mesh
for pelvic organ prolapse” [1]. In this multicenter random-
ized controlled trial, the use of a trocar-guided, transvaginal
polypropylene-mesh repair kit was compared with tradition-
al colporrhaphy in 389 women with prolapse of the anterior
vaginal wall. The primary outcome was a composite of
objective anatomical pelvic organ prolapse (POP) stage 0
or I [2] and the subjective absence of symptoms of vaginal
bulging 12 months after surgery. As compared with anterior
colporrhaphy, use of a standardized, trocar-guided mesh kit
for cystocele repair resulted in higher (60.8% versus 34.5%)
short-term rates of successful treatment. Surgical reinterven-
tion to correct mesh exposure during follow-up occurred in
3.2% of patients in the mesh-repair group.
We congratulate the authors on publishing a multicenter
randomized trial on a very controversial subject using inter-
nationally accepted validated outcome instruments. However,
we have the following concerns about the study set-up and the
way the data were presented.
For anatomic outcomes the authors used the POP-Q
system which clearly states:
“Point Aa: a point located in the midline of the anterior
vaginal wall 3 cm proximal to the external urethral
meatus, corresponding to the approximate location of
the ‘urethrovesical crease,’ a visible landmark of var-
iable prominence that is obliterated in many patients.
By definition, the range of position of point Aa rela-
tive to the hymen is −3 to +3 cm.
Point Ba: a point that represents the most distal (i.e.,
most dependent) position of any part of the upper ante-
rior vaginal wall from the vaginal cuff or anterior vag-
inal fornix to point Aa. By definition, point Ba is
at −3 cm in the absence of prolapse and would
have a positive value equal to the position of the
cuff in women with total post hysterectomy vaginal
eversion”.2
The authors present POP-Q values as median with ranges
in Table 1 in the Supplementary Appendix (original version,
before 23th of June). Ranges for point Aa vary from −4 to 5,
which, as noted above, is, by definition, not possible. The
same applies to values of point Ba which range from −8 to
7. Also, the authors state a value for point D of −13 which is
also not possible, since the maximal tvl (total vaginal
length) in the same table is 12. This would seem to indicate
that the POP-Q measurements were not performed accord-
ing to ICS standards. Since there are 21 ‘non-existing’
values in Table 1 (of the Supplementary Appendix), we
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have serious doubts about the anatomic outcomes the
authors’ report.
Apparently, the authors updated the Appendix on June
23, and a number of incorrect values were omitted in Table
1B. They state that “the incorrect values were omitted before
final analysis, while treatment assignment was still blinded.”
We wonder how many data or cases exactly were excluded
as no numbers are given in the table for crude or corrected
data. Furthermore, there is no recognition in the flow chart
(Fig. 1) of these patients that have been excluded at this
point.
The surgical procedure the patients received was either an
anterior tension-free vaginal mesh or an anterior colporrha-
phy. No concomitant surgery was permitted. How did the
specific study sites counsel their patients regarding the fact
that a portion of their prolapse would not be addressed, as in
patients in which the descending point of the posterior wall
was 4 cm beyond the hymen (Bp04, Table 1 Supplementary
Appendix) or if the cervix or vaginal apex was 4 or 6 cm
beyond the hymen (C04 and D06, Table 1 Supplementary
Appendix). Are we to assume that these segments of the
pelvic floor were ignored even though the prolapse extended
well beyond the hymen?
Finally, we were surprised that the authors only reported
on surgical reinterventions for mesh exposure (3.2%) and
did not report the total number of mesh exposures. Mesh
exposure is the most significant complication of transvagi-
nal mesh surgery for pelvic organ prolapse. The total per-
centage of mesh exposure is presented by virtually all
comparable papers and not presenting these data makes
comparison of this study with previous literature impossible.
Furthermore, only reporting on reinterventions of mesh
exposure is subject to considerable bias. The optimal indi-
cations and timing of reintervention is ultimately the deci-
sion of the individual surgeon, thus, potential bias such as
not to reintervene or to delay the reintervention until after
the study period is a real possibility.
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